Afya Limited Acquires RX PRO

Afya Limited Acquires Além da Medicina

March 4, 2022

Education

Afya Limited, through its wholly-owned subsidiary Afya Participações S.A., has completed the acquisition of 100% of Além da Medicina for an enterprise value of R$16.0 million paid in cash, with an additional earn-out of up to R$19.2 million tied to revenue targets for 2023–2024. Além da Medicina is a Brazilian online medical content and education platform serving physicians and medical students (more than 4,000 subscribers in 2021) and the deal is intended to strengthen Afya's digital content and medical education capabilities.

Afya Limited Acquires CardioPapers

April 5, 2022

Education

Afya Limited, through its subsidiary Afya Participações S.A., acquired 100% of CardioPapers, a Brazilian cardiology-focused medical education platform, for an enterprise value of R$35.0 million in cash plus an earn-out of up to R$15 million. The acquisition adds cardiology content and digital education capabilities to Afya's medical education ecosystem; CardioPapers reported ~7,000 students in 2021 and expected R$18.8 million gross revenue for 2022.

OptimizeRx Acquires RMDY Health

September 5, 2019

Cloud & SaaS

OptimizeRx Corporation (NASDAQ: OPRX) agreed to acquire RMDY Health, a digital therapeutics SaaS platform, for $16 million in cash and equity ($8M cash, $8M equity). The deal expands OptimizeRx's patient engagement capabilities into digital therapeutics and adds new client segments including payers, MedTech and medical associations; RMDY will retain its technology team in Tel Aviv while U.S. personnel will operate from OptimizeRx's U.S. offices.

ProPharma Group Acquires Pharmica Consulting

October 6, 2021

Healthcare Services

ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Pharmica Consulting, a life‑science consulting firm offering project management services and proprietary operations software for clinical trials. The acquisition expands ProPharma’s clinical and project‑management capabilities and enables Pharmica’s cloud‑based tools to be offered more broadly across ProPharma’s global client base.

Pfizer's Hospital Business Acquires Arixa Pharmaceuticals

October 22, 2020

Pharmaceuticals

Pfizer’s Hospital Business acquired Arixa Pharmaceuticals to advance development of Arixa’s lead oral prodrug ARX-1796, a potential oral beta-lactamase inhibitor + antibiotic combination. Financial terms were not disclosed; Arixa was a virtual, asset-light company based in Palo Alto and was advised by Four Oaks Partners on the transaction.

Afya Limited Acquires Glic

May 23, 2022

Healthcare Services

Afya Limited, through its subsidiary Afya Participações S.A., acquired 100% of Glic, a Brazil-based diabetes care and management app. The purchase (enterprise value R$22 million plus up to R$12 million in earn-outs) expands Afya’s digital services into the physician–patient relationship pillar and strengthens its healthtech ecosystem.